These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11994431)

  • 1. Cutting edge: selective impairment of CD8+ T cell function in mice lacking the TNF superfamily member LIGHT.
    Tamada K; Ni J; Zhu G; Fiscella M; Teng B; van Deursen JM; Chen L
    J Immunol; 2002 May; 168(10):4832-5. PubMed ID: 11994431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of genes coding for the tumor necrosis factor and lymphotoxin ligand-receptor system in non-Hodgkin's lymphomas.
    Warzocha K; Ribeiro P; Renard N; Bienvenu J; Charlot C; Coiffier B; Salles G
    Cancer Immunol Immunother; 2000 Nov; 49(9):469-75. PubMed ID: 11092613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel lymphotoxin alpha (LTalpha) knockout mice with unperturbed tumor necrosis factor expression: reassessing LTalpha biological functions.
    Liepinsh DJ; Grivennikov SI; Klarmann KD; Lagarkova MA; Drutskaya MS; Lockett SJ; Tessarollo L; McAuliffe M; Keller JR; Kuprash DV; Nedospasov SA
    Mol Cell Biol; 2006 Jun; 26(11):4214-25. PubMed ID: 16705172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting lymphotoxin-mediated negative selection to prevent prostate cancer in mice with genetic predisposition.
    Zhou P; Fang X; McNally BA; Yu P; Zhu M; Fu YX; Wang L; Liu Y; Zheng P
    Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17134-9. PubMed ID: 19805094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphotoxin and TNF: how it all began-a tribute to the travelers.
    Ruddle NH
    Cytokine Growth Factor Rev; 2014 Apr; 25(2):83-9. PubMed ID: 24636534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphotoxin beta receptor signaling is required for inflammatory lymphangiogenesis in the thyroid.
    Furtado GC; Marinkovic T; Martin AP; Garin A; Hoch B; Hubner W; Chen BK; Genden E; Skobe M; Lira SA
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5026-31. PubMed ID: 17360402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphotoxin signalling in immune homeostasis and the control of microorganisms.
    Upadhyay V; Fu YX
    Nat Rev Immunol; 2013 Apr; 13(4):270-9. PubMed ID: 23524463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of lymphotoxin in experimental models of infectious diseases: potential benefits and risks of a therapeutic inhibition of the lymphotoxin-beta receptor pathway.
    Spahn TW; Eugster HP; Fontana A; Domschke W; Kucharzik T
    Infect Immun; 2005 Nov; 73(11):7077-88. PubMed ID: 16239501
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis.
    Scheu S; Alferink J; Pötzel T; Barchet W; Kalinke U; Pfeffer K
    J Exp Med; 2002 Jun; 195(12):1613-24. PubMed ID: 12070288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LIGHT-deficiency impairs CD8+ T cell expansion, but not effector function.
    Liu J; Schmidt CS; Zhao F; Okragly AJ; Glasebrook A; Fox N; Galbreath E; Zhang Q; Song HY; Na S; Yang DD
    Int Immunol; 2003 Jul; 15(7):861-70. PubMed ID: 12807825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Licensed human natural killer cells aid dendritic cell maturation via TNFSF14/LIGHT.
    Holmes TD; Wilson EB; Black EV; Benest AV; Vaz C; Tan B; Tanavde VM; Cook GP
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):E5688-96. PubMed ID: 25512551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tumor necrosis factor family member TNFSF14 (LIGHT) is required for resolution of intestinal inflammation in mice.
    Krause P; Zahner SP; Kim G; Shaikh RB; Steinberg MW; Kronenberg M
    Gastroenterology; 2014 Jun; 146(7):1752-62.e4. PubMed ID: 24560868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical roles for LIGHT and its receptors in generating T cell-mediated immunity during Leishmania donovani infection.
    Stanley AC; de Labastida Rivera F; Haque A; Sheel M; Zhou Y; Amante FH; Bunn PT; Randall LM; Pfeffer K; Scheu S; Hickey MJ; Saunders BM; Ware C; Hill GR; Tamada K; Kaye PM; Engwerda CR
    PLoS Pathog; 2011 Oct; 7(10):e1002279. PubMed ID: 21998581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of T cell proliferation through the LIGHT-HVEM-BTLA cosignaling pathway.
    Cheung TC
    Recent Pat DNA Gene Seq; 2009; 3(3):177-82. PubMed ID: 19702559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LIGHT Is critical for IL-12 production by dendritic cells, optimal CD4+ Th1 cell response, and resistance to Leishmania major.
    Xu G; Liu D; Okwor I; Wang Y; Korner H; Kung SK; Fu YX; Uzonna JE
    J Immunol; 2007 Nov; 179(10):6901-9. PubMed ID: 17982081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LIGHT enhances the bactericidal activity of human monocytes and neutrophils via HVEM.
    Heo SK; Ju SA; Lee SC; Park SM; Choe SY; Kwon B; Kwon BS; Kim BS
    J Leukoc Biol; 2006 Feb; 79(2):330-8. PubMed ID: 16275888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphotoxin and LIGHT signaling pathways and target genes.
    Schneider K; Potter KG; Ware CF
    Immunol Rev; 2004 Dec; 202():49-66. PubMed ID: 15546385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of LIGHT in T cell-mediated immunity.
    Wang J; Fu YX
    Immunol Res; 2004; 30(2):201-14. PubMed ID: 15477661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LIGHT-HVEM signaling and the regulation of T cell-mediated immunity.
    Granger SW; Rickert S
    Cytokine Growth Factor Rev; 2003; 14(3-4):289-96. PubMed ID: 12787566
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.